MarketStudyReport.com adds “Global Imidacloprid (CAS 138261-41-3) Market Outlook 2016-2021” new report to its research database. The report spread across 101 pages with table and figures in it.
Imidacloprid is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids which act on the central nervous system of insects, with much lower toxicity to mammals. The chemical works by interfering with the transmission of stimuli in the insect nervous system. Specifically, it causes a blockage of the nicotinergic neuronal pathway. By blocking nicotinic acetylcholine receptors, imidacloprid prevents acetylcholine from transmitting impulses between nerves, resulting in the insect’s paralysis and eventual death. It is effective on contact and via stomach action. Because imidacloprid binds much more strongly to insect neuron receptors than to mammal neuron receptors, this insecticide is more toxic to insects than to mammals.
As of 1999, Imidacloprid was the most widely used insecticide in the world. Although it is now off patent, the primary manufacturer of this chemical is Bayer CropScience (part of Bayer AG). It is sold under many names for many uses; it can be applied by soil injection, tree injection, application to the skin of the plant, broadcast foliar, ground application as a granular or liquid formulation, or as a pesticide-coated seed treatment. Imidacloprid is widely used for pest control in agriculture. Other uses include application to foundations to prevent termite damage, pest control for gardens and turf, treatment of domestic pets to control fleas, protection of trees from boring insects, and in preservative treatment of some types of lumber products (e.g., Ecolife brand).
Browse full table of contents and data tables @ https://www.marketstudyreport.com/reports/global-imidacloprid-cas-138261-41-3-market-outlook-2016-2021-2/
Recent research suggests that widespread agricultural use of imidacloprid and other pesticides may be contributing to honey bee colony collapse disorder, the decline of honey bee colonies in Europe and North America observed since 2006. As a result, several countries have restricted use of imidacloprid and other neonicotinoids. In January 2013, the European Food Safety Authority stated that neonicotinoids pose an unacceptably high risk to bees, and that the industry-sponsored science upon which regulatory agencies’ claims of safety have relied, may be flawed, or even deceptive.
This report provides detailed analysis of worldwide markets for Imidacloprid (CAS 138261-41-3) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Imidacloprid (CAS 138261-41-3) market and further lays out an analysis of the factors influencing the supply/demand for Imidacloprid (CAS 138261-41-3), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Imidacloprid (CAS 138261-41-3) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Imidacloprid (CAS 138261-41-3) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Imidacloprid (CAS 138261-41-3) market are Bayer (Germany), Meghmani Organics (India), Atul Ltd (India), PCCPL (India), Sudarshan (India), BCIL (India), KWIN (China), Hailir (China), Jiangsu Changqing (China), Jiangsu Changlong (China), Ningbo Sunjoy Agroscience (China), Sino-Agri Union (China), Fengshan (China), Red Sun (China), Anhui Huaxing Chemical (China) , among others.
To receive personalized assistance, write to us @ email@example.com with the report title in the subject line along with your questions or call us at +1 866-764-2150